WELCOME TO OUR PARKINSON'S PLACE!

I HAVE PARKINSON'S DISEASES AND THOUGHT IT WOULD BE NICE TO HAVE A PLACE WHERE THE CONTENTS OF UPDATED NEWS IS FOUND IN ONE PLACE. THAT IS WHY I BEGAN THIS BLOG.

I COPY NEWS ARTICLES PERTAINING TO RESEARCH, NEWS AND INFORMATION FOR PARKINSON'S DISEASE, DEMENTIA, THE BRAIN, DEPRESSION AND PARKINSON'S WITH DYSTONIA. I ALSO POST ABOUT FUNDRAISING FOR PARKINSON'S DISEASE AND EVENTS. I TRY TO BE UP-TO-DATE AS POSSIBLE.

I AM NOT RESPONSIBLE FOR IT'S CONTENTS. I AM JUST A COPIER OF INFORMATION SEARCHED ON THE COMPUTER. PLEASE UNDERSTAND THE COPIES ARE JUST THAT, COPIES AND AT TIMES, I AM UNABLE TO ENLARGE THE WORDING OR KEEP IT UNIFORMED AS I WISH. IT IS IMPORTANT TO UNDERSTAND I AM A PERSON WITH PARKINSON'S DISEASE. I HAVE NO MEDICAL EDUCATION,

I JUST WANT TO SHARE WITH YOU WHAT I READ ON THE INTERNET. IT IS UP TO YOU TO DECIDE WHETHER TO READ IT AND TALK IT OVER WITH YOUR DOCTOR. I AM JUST THE COPIER OF DOCUMENTS FROM THE COMPUTER. I DO NOT HAVE PROOF OF FACT OR FICTION OF THE ARTICLE. I ALSO TRY TO PLACE A LINK AT THE BOTTOM OF EACH ARTICLE TO SHOW WHERE I RECEIVED THE INFORMATION SO THAT YOU MAY WANT TO VISIT THEIR SITE.

THIS IS FOR YOU TO READ AND TO ALWAYS KEEP AN OPEN MIND.

PLEASE DISCUSS THIS WITH YOUR DOCTOR, SHOULD YOU HAVE ANY QUESTIONS, OR CONCERNS. NEVER DO ANYTHING WITHOUT TALKING TO YOUR DOCTOR FIRST..

I DO NOT MAKE ANY MONEY FROM THIS WEBSITE. I VOLUNTEER MY TIME TO HELP ALL OF US TO BE INFORMED.

I WILL NOT ACCEPT ANY ADVERTISEMENT OR HEALING POWERS, HEALING FROM HERBS AND ETC. UNLESS IT HAS GONE THROUGH TRIALS AND APPROVED BY FDA. IT WILL GO INTO SPAM.

THIS IS A FREE SITE FOR ALL WITH NO ADVERTISEMENTS

THANK YOU FOR VISITING! TOGETHER WE CAN MAKE A DIFFERENCE!

TRANSLATE

Thursday, January 18, 2018

Specialized Physiotherapy for Parkinson's Reduces Costs, Disease-Related Complications

January 17, 2018

Specialized physiotherapists treated more patients than traditional physiotherapists.


Treatment of Parkinson disease (PD) through ParkinsonNet, a network of multidisciplinary, specialized allied health professionals, is associated with fewer disease-related complications, reduced healthcare costs, and fewer treatment sessions compared with usual physiotherapy PD care, according to study findings published in the Lancet Neurology.
In this observational study, investigators reviewed a database of health insurance claims consisting of patients in The Netherlands with PD who participated in physiotherapy. All patients were followed for approximately 3 years. A mixed-effects model was created to compare disease-related outcomes and healthcare costs associated with specialized PD care (ParkinsonNet, n=2129) vs usual physiotherapy (n=2252).
Specialized physiotherapy with ParkinsonNet was associated with significantly fewer disease-related complications compared with usual care physiotherapy (17% vs 21%, respectively; odds ratio 0.67; 95% CI, 0.56-0.81; <.0001). In addition, specialized physiotherapists treated a greater number of patients on an annual basis compared with usual care physiotherapists (mean 3.89 patients per therapist [SD 3.91] vs 1.48 [1.24], respectively). Investigators observed fewer treatment sessions in patients treated by specialized physiotherapists vs patients treated by usual care physiotherapists (mean 33.72 [SD 26.70] vs 47.97 [32.11], respectively).
Also, healthcare costs were lower in patients receiving care from specialized vs usual care physiotherapists, including direct costs (mean €933 [SD 843] vs €1329 [1021]; annual difference €395; 95% CI, 358-432; <.0001) and total healthcare costs (€2056 [3272] vs €2586 [3756]; €530; 95% CI, 391-669; <.0001). The risk for mortality was also lower in patients receiving care through ParkinsonNet vs usual care (6% vs 9%, respectively; =.001); however, a Cox survival model demonstrated no difference between the two care strategies (hazard ratio 0.86; 95% CI, 0.69-1.07; =.195).
The observational nature as well as potential referral bias are 2 limitations associated with this study. Further, the small percentage of PD-related complications in analyzed patients reduced the overall power of the findings.
Based on the results, the investigators of this study recommend that ParkinsonNet “should become usual care, and their use [should] be promoted by inclusion in guidelines for management of PD and by incentives for organizations that pay for PD care.”

Reference

Ypinga JHL, de Vries NM, Boonen LHHM, et al. Effectiveness and costs of specialised physiotherapy given via ParkinsonNet: a retrospective analysis of medical claims data[published online December 12, 2017]. Lancet Neurol. doi:10.1016/S1474-4422(17)30406-4
http://www.neurologyadvisor.com/movement-disorders/parkinsonnet-physiotherapy-cost-effective/article/737419/

No comments:

Post a Comment